A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia

Affiliations

• ¹ Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh PA; UPMC Hillman Cancer Center. [email protected].
• ² UPMC Hillman Cancer Center.
• ³ Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh PA; UPMC Hillman Cancer Center.
• ⁴ Department of Biostatistics, University of Pittsburgh School of Public Health.
• ⁵ UPMC Hillman Cancer Center, Pittsburgh, PA; Department of Pathology, University of Pittsburgh School of Medicine.
• ⁶ Immunologic Monitoring and Cellular Products Laboratory, UPMC Hillman Caner Center.
• ⁷ Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine.